Abstract
Background: Cancer is caused by mutations in oncogenes and loss of tumor suppressor activity. Despite the efforts of the pharmaceutical industry to fight cancer, it is necessary to investigate new methods to enhance the action against this disease. In this scenario, liposome technology has emerged as a drug delivery system for cancer treatment. The objective of this study was to evaluate the use of liposome technology in the treatment of cancer through analysis of patent documents.
Methods: We analyzed prospective documents in the Derwent Innovation Index database.
Results: A total of 203 patent documents were related to the area of interest, published between 2000 and 2020, and the USA and Japan were shown as countries with the largest number of publications. Moreover, most of these publications came from companies, however, also with the representation of important universities, mainly the University of California. According to the International Patent Classification, the codes most applicable to the documents were in the areas of human necessities and chemistry.
Conclusion: The results of this study showed that the study and application of liposomes for the development of cancer treatment tended to grow, along with the number of related patents.
Keywords: Cancer, liposome, drug delivery, patents, technological prospecting, patent analysis.
Recent Patents on Nanotechnology
Title:Application of Liposomes in Cancer Therapy: An Assessment of the Advancement of Technology Through Patent Documents
Volume: 15 Issue: 4
Author(s): Danielle D.G. Nunes, Ingrid L. Leal, Fabricia O. Oliveira, Tatiara L.R. da Silva, Valter de Senna and Bruna S. S. Machado*
Affiliation:
- SENAI Institute of Innovation (ISI) in Advanced Health Systems (CIMATEC ISI SAS), University Center SENAI/CIMATEC, National Service of Industrial Learning - SENAI, Salvador, Bahia,Brazil
Keywords: Cancer, liposome, drug delivery, patents, technological prospecting, patent analysis.
Abstract:
Background: Cancer is caused by mutations in oncogenes and loss of tumor suppressor activity. Despite the efforts of the pharmaceutical industry to fight cancer, it is necessary to investigate new methods to enhance the action against this disease. In this scenario, liposome technology has emerged as a drug delivery system for cancer treatment. The objective of this study was to evaluate the use of liposome technology in the treatment of cancer through analysis of patent documents.
Methods: We analyzed prospective documents in the Derwent Innovation Index database.
Results: A total of 203 patent documents were related to the area of interest, published between 2000 and 2020, and the USA and Japan were shown as countries with the largest number of publications. Moreover, most of these publications came from companies, however, also with the representation of important universities, mainly the University of California. According to the International Patent Classification, the codes most applicable to the documents were in the areas of human necessities and chemistry.
Conclusion: The results of this study showed that the study and application of liposomes for the development of cancer treatment tended to grow, along with the number of related patents.
Export Options
About this article
Cite this article as:
Nunes D.G. Danielle , Leal L. Ingrid , Oliveira O. Fabricia , da Silva L.R. Tatiara, de Senna Valter and Machado S. S. Bruna*, Application of Liposomes in Cancer Therapy: An Assessment of the Advancement of Technology Through Patent Documents, Recent Patents on Nanotechnology 2021; 15 (4) . https://dx.doi.org/10.2174/1872210514666201223093321
DOI https://dx.doi.org/10.2174/1872210514666201223093321 |
Print ISSN 1872-2105 |
Publisher Name Bentham Science Publisher |
Online ISSN 2212-4020 |
Call for Papers in Thematic Issues
Advances in Vanadium and Titanium Resources for High-performance Materials via Nanostructuring and Nanoengineering (updated BMS-NANOTEC-2023-HT-31)
Vanadium and titanium-based materials are ideal candidates for structural and functional materials in aerospace, biomedical engineering, optics, catalysis, energy storage and conversion etc. Vanadium/titanium-based alloys, compounds and materials have a large family with different chemical compositions, dimensions, structures/morphologies, and chemical/physical/mechanical properties, which provides huge opportunities for the development of emerging ...read more
Green Nanotechnology and Nanomaterials for a Sustainable Environment
Green nanotechnology (GN) might wind up being the most efficient platform for achieving the goals of the 2030 Agenda. The goal of GN is to create goods and procedures that are secure, energy-efficient, waste-free, and emit fewer greenhouse gases. Such goods and procedures use renewable resources, and/or their environmental impact ...read more
Nano-coatings and Nanoscale Composites for Hazardous Environments
Automobile, defence, and aerospace sectors need lightweight material for fuel efficiency and lower emissions. Often these materials are added with nanoscale reinforcements or have to be coated with nanomaterials to improve the scratch resistance, self-healing behaviour and corrosion and wear resistance and are all much needed for hazardous environments without ...read more
NANOSTRUCTURED NEUROMORPHIC DEVICES: TOWARDS IN MATERIA COMPUTING
The efforts pursued in the last decade to build up brain-inspired systems with electronic hardware solutions to solve complex data processing tasks, have leaded to the development of a new generation of devices, as memristor crossbar arrays, and their different applications became more and more reliable. One of the basic ...read more
Related Journals
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Enzymes To Die For: Exploiting Nucleotide Metabolizing Enzymes for Cancer Gene Therapy
Current Gene Therapy The Role of NF-κB Inhibitors in Cell Response to Radiation
Current Medicinal Chemistry Nitrosative Stress as a Mediator of Apoptosis: Implications for Cancer Therapy
Current Pharmaceutical Design Nanomedical Applications of Amphiphilic Dendrimeric Micelles
Current Medicinal Chemistry The Indolylcoumarin COUFIN Exhibits Potent Activity Against Renal Carcinoma Cells without Affecting Hematopoietic System
Anti-Cancer Agents in Medicinal Chemistry Targeting Vesicle Trafficking: An Important Approach to Cancer Chemotherapy
Recent Patents on Anti-Cancer Drug Discovery Recent Advances in Antibody-Drug Conjugates for Breast Cancer Treatment
Current Medicinal Chemistry Development and Clinical Application of Peptide-Based Radiopharmaceuticals
Current Pharmaceutical Design Advances in the Researches on the Biological Activities and Inhibitors of Phosphatidylinositol 3-kinase
Anti-Cancer Agents in Medicinal Chemistry Quadruplex-Forming Oligonucleotides as Tools in Anticancer Therapy and Aptamers Design: Energetic Aspects
Current Medicinal Chemistry - Anti-Cancer Agents Generation of Human Single-chain Antibody to the CD99 Cell Surface Determinant Specifically Recognizing Ewing’s Sarcoma Tumor Cells
Current Pharmaceutical Biotechnology Inhibition of Autophagy by Targeting ATG4B: Promises and Challenges of An Emerging Anti-cancer Strategy
Clinical Cancer Drugs Anti-Cancer Phytometabolites Targeting Cancer Stem Cells
Current Genomics The Function of LncRNA FTX in Several Common Cancers
Current Pharmaceutical Design A Systematic Review of Genes Involved in the Inverse Resistance Relationship Between Cisplatin and Paclitaxel Chemotherapy: Role of BRCA1
Current Cancer Drug Targets Can Soy Prevent Male Osteoporosis? A Review of the Current Evidence
Current Drug Targets Exploiting HPV-Induced Carcinogenesis for a Rational Drug Development in Cervical Cancer
Current Cancer Drug Targets Semaphorins and their Receptors in Stem and Cancer Cells
Current Medicinal Chemistry Pharmacological Aspects of the Enzastaurin-Pemetrexed Combination in Non-Small Cell Lung Cancer (NSCLC)
Current Drug Targets Liposomes: Targeted and Controlled Delivery System
Drug Delivery Letters